Relapsed/Refractory Rhabdomyosarcoma
specificRhabdomyosarcoma that does not respond to treatment.
9
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Relapsed/Refractory Rhabdomyosarcoma(9)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive | 55.6 |
| 2 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 55.6 |
| 3 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 55.6 |
| 4 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive | 55.6 |
| 5 | University of Illinois Cancer CenterChicago, IL | 55.6 |
| 6 | Cancer Center at IllinoisUrbana, IL | 55.6 |
| 7 | Penn State Cancer InstituteHershey, PA | 55.6 |
| 8 | University of Cincinnati Cancer CenterCincinnati, OH | 55.6 |
| 9 | Loma Linda University Cancer CenterLoma Linda, CA | 55.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →